Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Zhao, Chun ^a,b,c   Dong, Jing ^a   Jiang, Tao ^c   Shi, Zhonghua ^c   Yu, Bin ^d   Zhu, Yunlong ^e   Chen, Daozhen ^e   Xu, Junrong ^b   Huo, Ran ^a   Dai, Juncheng ^a   Xia, Yankai ^a   Pan, Shiyang ^b   Hu, Zhibin ^a   Sha, Jiahao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d Changzhou Maternity and Child Health Hospital   (China)

^e The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLYASE; MICRORNA; MICRORNA 132; MICRORNA 222; MICRORNA 29A; PHOSPHOENOLPYRUVATE CARBOXYKINASE 2; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN132 MICRORNA, HUMAN; MIRN222 MICRORNA, HUMAN; MIRN29 MICRORNA, HUMAN;

ADULT; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE SILENCING; GESTATIONAL AGE; HUMAN; HUMAN CELL; INSULIN INDUCED GENE 1; PREDICTION; PREGNANCY DIABETES MELLITUS; SECOND TRIMESTER PREGNANCY; VALIDATION STUDY; BLOOD; PREDICTIVE VALUE; PREGNANCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BIOLOGICAL MARKERS; DIABETES, GESTATIONAL; FEMALE; HUMANS; MICRORNAS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 80051977010     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023925     Document Type: Article

References (47)

1. Metzger BE, Coustan DR, (1998) Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21 (Suppl 2): B161-167.
2. American Diabetes Association (2004) Gestational diabetes mellitus. Diabetes Care 27 (Suppl 1): S88-90.
3. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, et al. (2005) Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28: 579-584.
4. Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM, (2004) An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstet Gynecol 103: 526-533.
5. Getahun D, Nath C, Ananth CV, Chavez MR, Smulian JC, (2008) Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol 198: 525 e521-525.
6. Ferrara A, (2007) Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30 (Suppl 2): S141-146.
7. Reece EA, (2010) The fetal and maternal consequences of gestational diabetes mellitus. J Matern Fetal Neonatal Med 23: 199-203.
8. Tieu J, Middleton P, McPhee AJ, Crowther CA, (2010) Screening and subsequent management for gestational diabetes for improving maternal and infant health. Cochrane Database Syst Rev 7: CD007222.
9. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
10. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
11. Lynn FC, Skewes-Cox P, Kosaka Y, McManus MT, Harfe BD, et al. (2007) MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 56: 2938-2945.
12. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230.
13. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, et al. (2006) MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 281: 26932-26942.
14. Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R, (2011) Diabetes mellitus, a microRNA-related disease? Transl Res 157: 253-264.
15. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
16. Zhang Y, Liu D, Chen X, Li J, Li L, et al. (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39: 133-144.
17. Herrera BM, Lockstone HE, Taylor JM, Ria M, Barrett A, et al. (2010) Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 53: 1099-1109.
18. Krapivner S, Chernogubova E, Ericsson M, Ahlbeck-Glader C, Hamsten A, et al. (2007) Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration. Diabetologia 50: 94-102.
19. He A, Zhu L, Gupta N, Chang Y, Fang F, (2007) Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 21: 2785-2794.
20. Thadhani R, Wolf M, Hsu-Blatman K, Sandler L, Nathan D, et al. (2003) First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus. Am J Obstet Gynecol 189: 171-176.
21. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, et al. (2003) First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 26: 819-824.
22. Smirnakis KV, Martinez A, Blatman KH, Wolf M, Ecker JL, et al. (2005) Early pregnancy insulin resistance and subsequent gestational diabetes mellitus. Diabetes Care 28: 1207-1208.
23. Smirnakis KV, Plati A, Wolf M, Thadhani R, Ecker JL, (2007) Predicting gestational diabetes: choosing the optimal early serum marker. Am J Obstet Gynecol 196: 410 e411-416; discussion 410 e416-417.
24. Hu Z, Chen X, Zhao Y, Tian T, Jin G, et al. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28: 1721-1726.
25. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, et al. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381.
26. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, et al. (2010) Circulating MicroRNAs in Patients With Coronary Artery Disease. Circ Res 107: 677-84.
27. Ai J, Zhang R, Li Y, Pu J, Lu Y, et al. (2010) Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 391: 73-77.
28. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, et al. (2010) Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes. Circ Res 107: 810-7.
29. Kong L, Zhu J, Han W, Jiang X, Xu M, et al. (2011) Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol 48: 61-69.
30. Ryan EA, Enns L, (1988) Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 67: 341-347.
31. Desoye G, Hauguel-de Mouzon S, (2007) The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 30 (Suppl 2): S120-126.
32. Chen J, Tan B, Karteris E, Zervou S, Digby J, et al. (2006) Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 49: 1292-1302.
33. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB, (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798.
34. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
35. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
36. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
37. Chakravarty K, Leahy P, Becard D, Hakimi P, Foretz M, et al. (2001) Sterol regulatory element-binding protein-1c mimics the negative effect of insulin on phosphoenolpyruvate carboxykinase (GTP) gene transcription. J Biol Chem 276: 34816-34823.
38. Becard D, Hainault I, Azzout-Marniche D, Bertry-Coussot L, Ferre P, et al. (2001) Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 50: 2425-2430.
39. Chakravarty K, Wu SY, Chiang CM, Samols D, Hanson RW, (2004) SREBP-1c and Sp1 interact to regulate transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in the liver. J Biol Chem 279: 15385-15395.
40. Du B, Ma LM, Huang MB, Zhou H, Huang HL, et al. (2010) High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett 584: 811-816.
41. Visone R, Russo L, Pallante P, De Martino I, Ferraro A, et al. (2007) MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 14: 791-798.
42. Esguerra JL, Bolmeson C, Cilio CM, Eliasson L, (2011) Differential Glucose-Regulation of MicroRNAs in Pancreatic Islets of Non-Obese Type 2 Diabetes Model Goto-Kakizaki Rat. PLoS One 6: e18613.
43. Kroh EM, Parkin RK, Mitchell PS, Tewari M, (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298-301.
44. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
45. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179.
46. Tang F, Hajkova P, Barton SC, Lao K, Surani MA, (2006) MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 34: e9.
47. Zhao C, Guo XJ, Shi ZH, Wang FQ, Huang XY, et al. (2009) Role of translation by mitochondrial-type ribosomes during sperm capacitation: an analysis based on a proteomic approach. Proteomics 9: 1385-1399.